AKUMS
Invest with MTF
Invest Now
Invest in Akums Drugs & Pharmaceuticals with 3.31X leverage
Performance
- Low
- ₹451
- High
- ₹460
- 52 Week Low
- ₹405
- 52 Week High
- ₹623
- Open Price₹457
- Previous Close₹464
- Volume21,304
- 50 DMA₹444.29
- 100 DMA₹452.55
- 200 DMA₹493.77
Investment Returns
- Over 1 Month + 2.09%
- Over 3 Month + 0.1%
- Over 6 Month -5.71%
- Over 1 Year -17.52%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 22.5
- PEG Ratio
- 1.6
- Market Cap Cr
- 7,139
- P/B Ratio
- 2.3
- Average True Range
- 12.88
- EPS
- 19.54
- Dividend Yield
- 0
- MACD Signal
- 3.88
- RSI
- 63.24
- MFI
- 77.01
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹453.60
-10.4
(-2.24%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹449.31
- 50 Day
- ₹444.29
- 100 Day
- ₹452.55
- 200 Day
- ₹493.77
Resistance and Support
466.3
- R3 479.10
- R2 475.60
- R1 469.80
- S1 460.50
- S2 457.00
- S3 451.20
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹453 As on 13 February, 2026 | 11:01
The Market Cap of Akums Drugs & Pharmaceuticals is ₹7139.4 Cr As on 13 February, 2026 | 11:01
The P/E ratio of Akums Drugs & Pharmaceuticals is 22.5 As on 13 February, 2026 | 11:01
The PB ratio of Akums Drugs & Pharmaceuticals is 2.3 As on 13 February, 2026 | 11:01
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.